Boardroom Alpha
Boardroom Alpha
CVR · Current Report (Form 8-K) · Filed May 15, 2025

Chicago Rivet & Machine Co — Current Report (Form 8-K)

Form
8-K
Filed
May 15, 2025
Period
May 13, 2025
Ticker
CVR
Accession
0000950170-25-072698
Boardroom Alpha · Filing insights

Seven directors elected for 2026 term; say-on-pay approved; Crowe LLP ratified; pay vote frequency set to every 3 years.

About Chicago Rivet & Machine Co
Market cap
$10M
1Y TSR
−22.1%
3Y TSR
−25.5%
Board grade
C
Sector
Industrials
CEO
Gregory D Rizzo
Last annual meeting: May 12, 2026 · View full Chicago Rivet & Machine Co profile →
8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT TO

SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) May 13, 2025

Chicago Rivet & Machine Co.

(Exact Name of Registrant as Specified in Its Charter)

Illinois

000-01227

36-0904920

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

27755 Diehl Road, Suite 200, Warrenville, Illinois

60555

(Address of Principal Executive Offices)

(Zip Code)

Registrant's telephone number, including area code (630) 357-8500

901 Frontenac Road, Naperville, Illinois, 60563

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $1.00 per share

CVR

NYSE American  (Trading privileges only, not registered)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company's Annual Meeting of Stockholders was held on May 13, 2025. At the meeting, (1) the seven nominees named in the Company's proxy statement dated April 4, 2025 were elected to serve for a term ending at the Annual Meeting in 2026, (2) the advisory vote on executive compensation was approved, and (3) the selection of Crowe LLP to serve as the Company's independent registered public accounting firm for 2025 was ratified.

The voting results for each proposal are set forth below:

Election of Directors:

 

Votes For

Votes Withheld

Broker Non-Votes

Kent H. Cooney

466,601

26,885

321,475

Kurt Moders

466,811

26,675

321,475

James W. Morrissey

468,087

25,399

321,475

Walter W. Morrissey, M.D.

466,526

26,960

321,475

Karen G. Ong

466,960

26,526

321,475

Gregory D. Rizzo

466,614

26,872

321,475

John L. Showel

466,929

26,557

321,475

 

Approval, by non-binding vote, of the Company's executive compensation as described in the Company's 2025 proxy statement:

Votes For

Votes Against

Abstentions

Broker Non-Votes

456,273

28,584

8,629

321,475

 

Advisory vote on the frequency of future advisory votes on executive compensation:

1 year

2 years

3 years

Abstentions

Broker Non-Votes

144,030

2,273

338,333

8,850

321,475

 

Ratification of Crowe LLP as the Company's independent registered public accounting firm for 2025:

Votes For

Votes Against

Abstentions

Broker Non-Votes

799,488

9,167

6,306

0

 

Following the Company’s Annual Meeting of Stockholders, the Company determined that an advisory vote on executive compensation would be held every three years until the next advisory vote on the frequency of advisory votes regarding executive compensation.

 

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHICAGO RIVET & MACHINE CO.

 Date: May 15, 2025

By: /s/ Gregory D. Rizzo

 

Name: Gregory D. Rizzo

Title: Chief Executive Officer


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Chicago Rivet & Machine Co (CVR)

Reference

Frequently asked questions

When did Chicago Rivet & Machine Co file this 8-K?
Chicago Rivet & Machine Co (CVR) filed this Current Report (Form 8-K) with the SEC on May 15, 2025. The accession number assigned by EDGAR is 0000950170-25-072698.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Seven directors elected for 2026 term; say-on-pay approved; Crowe LLP ratified; pay vote frequency set to every 3 years. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Chicago Rivet & Machine Co's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Chicago Rivet & Machine Co has filed under CIK 19871, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer